/
•
•
Eyes are on the stock markets today as they respond to mixed cues—tax relief from GST reforms as well as the implications of Trump's $100,000 H-1B visa fee hike.

The FMCG major returns to acquisitions as growth stalls, but its uneven track record and structural challenges raise questions over whether the strategy can deliver
A public listing will help clean up the hospital chain’s balance sheet after the costly Sahyadri acquisition. But depressed metrics, integration risks and lofty valuations make this far from a clean turnaround story.
Fiscal discipline holds on paper, but the number is propped up by higher borrowing and revenue sources that are far from stable.